The main aim of the LID is to understand the pathogenesis of important respiratory and enteric viral pathogens of humans and to develop means to prevent illness caused by these viruses. The purpose of the new contract is to provide volunteers and a facility in which to study the biology of medically important viruses in humans, to examine the hosts immune response to these viruses, and to test new candidate live virus vaccines for safety, genetic stability, immunogenicity, transmissibility and protective efficacy. Studies will also include administration of wild type viruses to volunteers in order to assess virulence. Subsequently, these wild type viruses will be used to challenge vaccinated volunteers in order to assess the extent of immunity induced by candidate vaccines. Studies with vaccines will include an evaluation of their safety, immunogenicity, transmissibility, and protective efficacy. These studies will include both adult and pediatric subjects since the viruses studied cause disease in both these populations; e.g., influenza A viruses cause severe respiratory disease in the elderly and, conversely, respiratory syncytial virus causes severe respiratory disease in infants. In summary, the new contract facility will provide facilities and populations to study the biology and immunology of a variety of viral pathogens and will serve as a testing center for the development of new vaccines effective against these agents.

Project Start
1985-12-01
Project End
1990-11-30
Budget Start
1986-08-27
Budget End
1987-11-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
Schools of Medicine
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Rennels, Margaret B; Deloria, Maria A; Pichichero, Michael E et al. (2002) Lack of consistent relationship between quantity of aluminum in diphtheria-tetanus-acellular pertussis vaccines and rates of extensive swelling reactions. Vaccine 20 Suppl 3:S44-7
Meade, B D; Deforest, A; Edwards, K M et al. (1995) Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 96:570-5
Deloria, M A; Blackwelder, W C; Decker, M D et al. (1995) Association of reactions after consecutive acellular or whole-cell pertussis vaccine immunizations. Pediatrics 96:592-4
Meade, B D; Lynn, F; Reed, G F et al. (1995) Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines. Pediatrics 96:595-600
Edwards, K M; Meade, B D; Decker, M D et al. (1995) Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96:548-57
Decker, M D; Edwards, K M; Steinhoff, M C et al. (1995) Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96:557-66
Steinhoff, M C; Reed, G F; Decker, M D et al. (1995) A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines. Pediatrics 96:567-70
Rennels, M B; Reed, G F; Decker, M D et al. (1995) Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines. Pediatrics 96:576-9
Englund, J A; Anderson, E L; Reed, G F et al. (1995) The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 96:580-4
Christy, C; Pichichero, M E; Reed, G F et al. (1995) Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics 96:584-7

Showing the most recent 10 out of 16 publications